Clinical trials: Gastroesophageal Varices
Gastroesophageal Varices
Dual Energy CT as a Noninvasive Method to Screen for Gastroesophageal Varices
Cirrhosis leads to portal hypertension and development of gastroesophageal varices, which are the most common cause for bleeding in cirrhosis and a major cause of death.
- Trial name
- NCT03910413
- Testing
- Duel Energy CT
- Where
- United States
- Volunteers
- 11 people
- Sponsor
- University of Alabama at Birmingham
Liver Cirrhosis, Hypertension, Portal
PPIs and Gastroesophageal Varices in Liver Cirrhosis (PPIs: Proton Pump Inhibitors)
This study is aimed at investigating the effect of PPIs on gastroesophageal varices in liver cirrhosis. Half of participants will receive PPI, while the other half will receive a placebo.
- Trial name
- PPIs (NCT03175731)
- Testing
- Proton Pump Inhibitors
- Where
- China
- Volunteers
- 106 people
- Sponsor
- Yanjing Gao